CONCERT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about news in CONCERT PHARMACEUTICALS, INC..

The service is free and you can unsubscribe at any time.

General | People (81) | Filings (232) | Annual reports (3) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001367920

CONCERT PHARMACEUTICALS, INC. is a publicly traded company

Trading symbol: CNCE

News

2017-06-22

Concert Pharmaceuticals Inc. (CNCE) Soars 5.94% on June 22
Equities.com
Concert Pharmaceuticals Inc. (CNCE) had a good day on the market for Thursday June 22 as shares jumped 5.94% to close at $14.63.
Concert Pharmaceuticals (CNCE) Receives Daily News Impact Score of -0.12 - The Cerbat Gem
The Aegis Reaffirms Buy Rating for Concert Pharmaceuticals, Inc. (CNCE) - BangaloreWeekly

2017-06-21

Great Point Partners Llc Buys Concert Pharmaceuticals Inc, Rigel ...
GuruFocus.com
Greenwich, CT, based Investment company Great Point Partners Llc buys Concert Pharmaceuticals Inc, Rigel Pharmaceuticals Inc, PTC Therapeutics Inc, Synergy Pharmaceuticals Inc, Paratek Pharmaceuticals Inc, NeuroDerm, Acceleron Pharma Inc, Aurinia ...

2017-06-21

Concert Pharmaceuticals Inc. (CNCE) Soars 5.18% on June 21
Equities.com
Concert Pharmaceuticals Inc. (CNCE) had a good day on the market for Wednesday June 21 as shares jumped 5.18% to close at $13.81.

2017-06-21

Concert Pharmaceuticals' (CNCE) Buy Rating Reaffirmed at Aegis
The Cerbat Gem
Concert Pharmaceuticals logo Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)'s stock had its “buy” rating reaffirmed by Aegis in a research report issued to clients and investors on Monday, June 12th.
A Look at 2 Trending Stocks: Belden Inc. (BDC), Concert Pharmaceuticals, Inc ... - Post Analyst
KCG Holdings Inc. Buys Shares of 66897 Concert Pharmaceuticals, Inc. (CNCE) - Markets Daily

2017-06-15

Decision Time: Concert Pharmaceuticals Inc (NASDAQ:CNCE) Stock Technicals Hit ...
CML News
Decision Time: Concert Pharmaceuticals Inc (NASDAQ:CNCE) now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point.

2017-06-14

Aegis Reiterates Buy Rating for Concert Pharmaceuticals, Inc. (CNCE)
The Cerbat Gem
Concert Pharmaceuticals logo Concert Pharmaceuticals, Inc. (NASDAQ:CNCE)'s stock had its “buy” rating restated by equities research analysts at Aegis in a note issued to investors on Monday.
8400 Shares in Concert Pharmaceuticals, Inc. (CNCE) Acquired by Hillsdale ... - Transcript Daily
Concert Pharmaceuticals (CNCE) Earns News Impact Score of 0.04 - Stock Observer

2017-06-12

Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE) Quant Investor Update
Ozark Times
Concert Pharmaceuticals, Inc. (NasdaqGM:CNCE) has a Q.i. Value of 86.00000. The purpose of the Q.i. Value is to help identify companies that are the most undervalued.

CONCERT PHARMACEUTICALS, INC. address

99 HAYDEN AVENUE
SUITE 500
LEXINGTON
02421

Former name

Former name of this company was CONCERT PHARMACEUTICALS INC, date of change: 2006-06-28.

Earliest known filing

June 2006

Latest known filing

June 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

CONCERT PHARMACEUTICALS, INC. has 232 filings. View CONCERT PHARMACEUTICALS, INC. filings.

Annual Reports

Quarterly Reports

Latest company events

People

We have found 81 people related to CONCERT PHARMACEUTICALS, INC..

Similar companies

CONCERTSBYU COM INC, CONCERTS INC, CONCERTO SOFTWARE INC, Concerto Software (Japan) Corp, CONCERTO NETWORKS INC, Concerto Healthcare, Inc., Concerto Credit Opportunity Fund I, LP, Concert Window, Inc., Concert Wealth Management Inc., CONCERT TECHNOLOGY CORP, CONCERT PRODUCTIONS UK LTD, CONCERT PRODUCTIONS INTERNATIONAL B V, CONCERT NETWORK INC, Concert Network Inc, Concert Group Logistics, LLC, Concert Golf Investors, LLC, CONCERT Global Group, Ltd., Concert Financial, LLC, CONCERT CAPITAL LLC, CONCERT ATLANTA INVESTORS LLC, Concert 64, Inc.